Search results
JN.1 COVID Variant Symptoms vs. Allergy Symptoms
Verywell Health via Yahoo News· 2 days agoThe JN.1 COVID variant has slightly different symptoms than other variants, as well as some differences when compared to seasonal allergies. Here's what...
Data: Optimal initiation of Paxlovid in hospitalized COVID patients is 3 to 5 days
Center for Infectious Disease Research and Policy· 2 hours agoTaking the SARS-CoV-2 antiviral drug nirmatrelvir-ritonavir (Paxlovid) 3 to 5 days after COVID-19 ...
Loss Of Smell Might Persist Even One Year After A Covid-19 Infection
Forbes· 13 hours agoThe latter is due to molecules reaching the olfactory receptors from the oral cavity via the...
Tri-State clinics and trials help patients with long COVID
Local 12 Cincinnati· 1 day agoWhile new cases of the novel SARS-CoV-2 virus are down, infectious disease specialist Dr. Stephen...
Blood Biomarkers Reveal the Hidden World of Long COVID
SciTechDaily· 5 days agoA new study on long COVID reveals unique immune patterns related to symptoms, advocating for...
Are Monoclonal Antibodies the Future of Long COVID Treatments?
Technology Networks· 2 days agoOne study published in PLOS Pathogens in 2022 found that long COVID patients had 100 times the...
Patient Had COVID-19 for Record 613 Days
Time Magazine· 6 days agoA Covid-19 patient with a weakened immune system incubated a highly mutated novel strain over 613 days before succumbing to an underlying illness,...
Optimal timing maximizes Paxlovid benefits for treating COVID-19
Medical Xpress· 22 hours agoResearchers have described the optimal timing for COVID-19 patients to take the antiviral, Paxlovid, to get the most benefit from the treatment, according to a study published April 16 in eLife ...
Sanders’ long COVID funding bill misses opportunity to aid a similar chronic condition
The Hill· 23 hours agoSen. Bernie Sanders’ (I-Vt.) recent call for $10 billion in research grants over ten years for long...
RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study
WCMH Columbus· 7 hours agoRALEIGH, N.C. and TEL-AVIV, Israel, April 24, 2024 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...